Verastem reported $-14806000 in EBIT for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
AstraZeneca AZN:LN -4000000 1.45B
Curis CRIS:US $ -10048000 602K
Cytokinetics CYTK:US $ -69201000 14.4M
Epizyme EPZM:US $ -64140000 5.91M
Gilead Sciences GILD:US $ 3883M 1637M
Immunogen IMGN:US $ -34234000 6.86M
Laboratory Of America LH:US $ 778.6M 52.9M
Novartis NOVN:VX 3.48B 77M
Pfizer PFE:US $ 9254M 2592M
Tg Therapeutics TGTX:US $ -85128000 7.64M
Verastem VSTM:US $ -14806000 1.14M
YTE INCY:US $ 247.47M 92.16M